71 related articles for article (PubMed ID: 23639859)
1. Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: a pilot study.
Kato S; Endo I; Fujimura M; Kuriwaka-Kido R; Fujinaka Y; Aihara K; Iwase T; Inoue D; Akaike M; Abe M; Matsumoto T
Atherosclerosis; 2013 Jul; 229(1):182-5. PubMed ID: 23639859
[TBL] [Abstract][Full Text] [Related]
2. Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors.
Kondo T; Endo I; Aihara K; Onishi Y; Dong B; Ohguro Y; Kurahashi K; Yoshida S; Fujinaka Y; Kuroda A; Matsuhisa M; Fukumoto S; Matsumoto T; Abe M
Endocr J; 2016 Apr; 63(4):397-404. PubMed ID: 26877258
[TBL] [Abstract][Full Text] [Related]
3. [Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease].
Deng Y; Chen LH; Wang XB; Song XD; Ling YN; Chen AH; Yang PZ; Guo JB; Que DD; Chen GM
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):506-10. PubMed ID: 25907933
[TBL] [Abstract][Full Text] [Related]
4. Circulating cathepsin K as a potential novel biomarker of coronary artery disease.
Cheng XW; Kikuchi R; Ishii H; Yoshikawa D; Hu L; Takahashi R; Shibata R; Ikeda N; Kuzuya M; Okumura K; Murohara T
Atherosclerosis; 2013 May; 228(1):211-6. PubMed ID: 23369704
[TBL] [Abstract][Full Text] [Related]
5. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque.
Kojima S; Kojima S; Maruyoshi H; Nagayoshi Y; Kaikita K; Sumida H; Sugiyama S; Funahashi T; Ogawa H
Int J Cardiol; 2011 Mar; 147(3):371-6. PubMed ID: 19896734
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
[TBL] [Abstract][Full Text] [Related]
7. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
[TBL] [Abstract][Full Text] [Related]
8. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma.
Nabeya Y; Shimada H; Okazumi S; Matsubara H; Gunji Y; Suzuki T; Ochiai T
Cancer; 2002 Feb; 94(4):940-9. PubMed ID: 11920462
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.
Berger CE; Kröner A; Stiegler H; Leitha T; Engel A
Int Orthop; 2005 Feb; 29(1):1-5. PubMed ID: 15625614
[TBL] [Abstract][Full Text] [Related]
10. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
11. Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndrome.
Taguchi I; Koizumi S; Kageyama M; Nasuno T; Toyoda S; Abe S; Node K; Inoue T
Int J Cardiol; 2014 May; 173(2):329-31. PubMed ID: 24680249
[No Abstract] [Full Text] [Related]
12. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression.
Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; Möttönen T;
Scand J Rheumatol; 2008; 37(2):90-3. PubMed ID: 18415764
[TBL] [Abstract][Full Text] [Related]
13. Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study).
Kelly CR; Weisz G; Maehara A; Mintz GS; Mehran R; Lansky AJ; Parise H; de Bruyne B; Serruys PW; Stone GW
Am J Cardiol; 2014 Aug; 114(3):376-83. PubMed ID: 24931291
[TBL] [Abstract][Full Text] [Related]
14. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
15. Association of soluble tumour necrosis factor-related apoptosis-inducing ligand levels with coronary plaque burden and composition.
Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Panagopoulou V; Miliou A; Theodorakis A; Driva M; Pyrgakis V; Stefanadis C; Cleman MW
Heart; 2012 Feb; 98(3):214-8. PubMed ID: 21965221
[TBL] [Abstract][Full Text] [Related]
16. Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function.
Kitahara T; Takeishi Y; Arimoto T; Niizeki T; Koyama Y; Sasaki T; Suzuki S; Nozaki N; Hirono O; Nitobe J; Watanabe T; Kubota I
Circ J; 2007 Jun; 71(6):929-35. PubMed ID: 17526992
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
Fan X; Wang E; Wang X; Cong X; Chen X
Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tissue type plasminogen activator and coronary vulnerable plaque in patients with acute coronary syndrome: virtual histological study.
Wang HB; Kang WQ; Song DL; Wang X; Ren GR; Teng JL; Ge ZM
Chin Med J (Engl); 2008 Mar; 121(6):540-3. PubMed ID: 18364143
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of circulating markers of collagen turnover after acute myocardial infarction.
Manhenke C; Orn S; Squire I; Radauceanu A; Alla F; Zannad F; Dickstein K
Int J Cardiol; 2011 Aug; 150(3):277-82. PubMed ID: 20493567
[TBL] [Abstract][Full Text] [Related]
20. Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma.
Nurmenniemi S; Koivula MK; Nyberg P; Tervahartiala T; Sorsa T; Mattila PS; Salo T; Risteli J
Oral Oncol; 2012 Feb; 48(2):136-40. PubMed ID: 21945070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
